capacity and higher sale price compared to 1st quarter 2019. As a result, revenue from sales increased by 12.83 percent from the same period of last year. Other income decreased significantly 66.03 percent

2018, Cost of sales was 4,160 MTHB, increased by 231 MTHB comparing to 2017 or 5.9% as a result of greater Ethylene and Glycerin price from higher crude oil price and their limited supply. 2. In Q3 2018

subsidiaries have the revenues from medical treatment of 947.83 million baht, which is a 7.48 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

subsidiaries have the revenues from medical treatment of 899.25 million baht, which is a 15.55 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

{A} for executing their trading orders.{A} later resigned from Globlex to work for KTB where she made trading orders in the derivatives accounts of several clients who had given her their usernames and

was decreased as a result of profit for the period was decreased 40.12 Million Baht. (The third quarter of 2017, there were profit for the period 30.42 Million Baht.) Revenue from sales were 481.82

in charge of Accounting and Finance of ICHI, knew the inside information related to ICHI's financial statement year 2016, which would show a decline in the net earnings resulting from net operating

, which do not take into account the extra income in the year 2016 as shows that the company's net profit increased from the last year as a result of normal operations. The net profit excluded extra income

recorded from the change in the Company’s ownership interest from 28.49% to 20.56% as a consequence of newly issued ordinary shares of Pimai Salt Company Limited. * Note Please find further information in

income tax expenses 5.93 6.12 3.55 2.57 72.53 Share of profit from investment in joint venture 0.90 - - - N/A Profit before financial costs and income tax expenses 6.83 6.12 3.55 2.57 72.53 Financial costs